West Pharmaceutical Services | WST - Ebit

Stock Price
230.95
Daily Change
-6.55 -2.76%
Monthly
-17.23%
Yearly
-30.24%
Q1 Forecast
224.00

West Pharmaceutical Services reported $167.6M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Align Technology USD 184.65M 21.61M Sep/2025
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Charles River Laboratories USD 133.8M 1.46M Sep/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dentsply International USD 512M 401M Sep/2025
Haemonetics USD 81.1M 10.26M Sep/2025
ICU Medical USD 26.86M 52K Sep/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 521.67M Sep/2025
IQVIA Holdings USD 573M 17M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Medtronic USD 1.7B 100M Sep/2025
Merit Medical Systems USD 42.61M 7.54M Sep/2025
Neogen USD -5.38M 10.71M Sep/2025
Quidel USD 45.2M 47M Sep/2025
Repligen USD 16.81M 10.85M Sep/2025
Solventum Corp USD 1.69B 1.47B Sep/2025
STAAR Surgical USD -24.72M 10.02M Jun/2025
Terumo JPY 45.1B 10.79B Sep/2025
West Pharmaceutical Services USD 167.6M 13.9M Sep/2025